France’s Sanofi to carve out active drug ingredients firm
FILE PHOTO: The logo of Sanofi is seen during the annual results news conference in Paris, France, February 6, 2020.…
Sanofi pulls Zantac from U.S. and Canada after carcinogen found
NEW YORK (Reuters) – Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States…
Sanofi to pay Lexicon $260 million for terminated partnership
The logo of Sanofi is seen at the company’s research and production centre in Vitry-sur-Seine, France, August 6, 2019. REUTERS/Charles…
Philippines weighs re-use of controversial dengue vaccine
FILE PHOTO: Boxes of anti-dengue vaccine Dengvaxia are placed inside a freezer for storage at the Manila Health Department in…
Sanofi ends partnership with Lexicon to develop diabetes drug
FILE PHOTO: A logo of Sanofi is pictured during the company’s shareholders meeting in Paris, France, April 30, 2019. REUTERS/Benoit…
Sanofi signs U.S. rights deal with Roche for flu treatment Tamiflu
FILE PHOTO: A logo of Sanofi is pictured during the company’s shareholders meeting in Paris, France, April 30, 2019. REUTERS/Benoit…
FDA approves expanded label for Regeneron/Sanofi’s cholesterol drug
(Reuters) – The U.S. Food and Drug Administration on Friday approved Regeneron Pharmaceuticals Inc’s cholesterol drug Praluent as a treatment…
FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes
(Reuters) – The U.S. Food and Drug Administration declined to approve a drug developed by Sanofi SA and Lexicon Pharmaceuticals…
Exclusive: Sanofi says working on CEO succession plan
PARIS (Reuters) – Pharmaceuticals group Sanofi is working on a plan to find a new CEO in agreement and consultation…
Sanofi blood disorder drug wins FDA approval
(Reuters) – The U.S. Food and Drug Administration (FDA) said on Wednesday it had approved Sanofi SA’s drug to treat…
Sanofi drug Dupixent wins FDA approval to treat asthma
(Reuters) – France’s Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration…
More drugmakers build Brexit stockpiles as EU agency faces exodus
PARIS/ZURICH/LONDON (Reuters) – Sanofi (SASY.PA) and Novartis (NOVN.S) said on Wednesday they planned to increase stockpiles of medicines in Britain…
Regeneron/Sanofi cut heart drug price to $4,500-$6,600 for Express Scripts
(Reuters) – Regeneron Pharmaceuticals Inc and Sanofi SA will slash the price of their expensive cholesterol drug for Express Scripts…